By 2050, one in three Americans is expected to have diabetes and will be at increased risk for dementia. While diabetes is associated with reduced availability of central insulin, little is known about how this deficiency specifically alters neuronal function, particularly in the acute state. Insulin has been shown to affect neuronal signaling, akin to a classic neuromodulator, where it can act on inhibitory and/or excitatory neurotransmission. Yet fundamental questions remain about how the loss of insulin receptor signaling might affect intact neuronal networks in vivo, and thus the biophysical behavior of neuronal membranes and molecular signaling that is important for learning and memory. Murine primary sensory cortex provides a model that enables these questions to be addressed. It has clear and well-known physiological roles in both sensory coding and learning, and advanced tools are available to quantify the effects of experimental changes, such as insulin-mediated neuromodulation. Questions asked in this animal model can be further explored in both mutant and transgenic mouse lines that yield diabetic phenotypes. Here we propose to use molecular biology, patch-clamp recording, and multi-electrode arrays coupled to in vivo pharmacology to elucidate roles for insulin neuromodulation at central sensory neurons. Experiments will be carried out in wildtype, untreated, and insulin-treated mutant Akita mice (model of insulin deficient Type 1 diabetes). Scientifically, this proposal is organized to address three main aims. We will determine: 1) the functional organization of insulin-associated circuits, and demonstrate the extent to which these networks are engaged by auditory experience 2) how insulin, and its deficiency, affects synaptic transmission in A l , and 3) how insulin, or dysfunctional insulin signaling, modulates the physiology of Al neurons during auditory processing and discrimination in the awake brain. The work proposed in this application is an important first step to investigate a possible need for the lifelong regulation of central insulin in people with diabetes. Moreover, the data may also support the use of treatments such as intra-nasal insulin to combat diabetes related cognitive impairment and dementias.

Public Health Relevance

Diabetes doubles one's risk for Alzheimer's disease or other dementias. While dementia patients treated with centrally acting insulin experience improved cognitive function, potential benefits of central insulin treatment in diabetics are not known. In part, this is because the physiological impacts of central insulin and the effects of its loss in diabetes are poorly understood. To address this gap, this study examines neuromodulatory roles of central insulin in wildtype and mutant mice with type 1 diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
5P20GM104934-07
Application #
8542666
Study Section
Special Emphasis Panel (ZRR1-RI-B)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
7
Fiscal Year
2013
Total Cost
$205,697
Indirect Cost
$66,712
Name
University of Oklahoma Health Sciences Center
Department
Type
DUNS #
878648294
City
Oklahoma City
State
OK
Country
United States
Zip Code
73117
Chen, Qian; Qiu, Fangfang; Zhou, Kelu et al. (2017) Pathogenic Role of microRNA-21 in Diabetic Retinopathy Through Downregulation of PPAR?. Diabetes 66:1671-1682
Li, Manna; Qian, Ming; Xu, Jian (2017) Vascular Endothelial Regulation of Obesity-Associated Insulin Resistance. Front Cardiovasc Med 4:51
Pearsall, Elizabeth A; Cheng, Rui; Zhou, Kelu et al. (2017) PPAR? is essential for retinal lipid metabolism and neuronal survival. BMC Biol 15:113
Vadvalkar, Shraddha S; Matsuzaki, Satoshi; Eyster, Craig A et al. (2017) Decreased Mitochondrial Pyruvate Transport Activity in the Diabetic Heart: ROLE OF MITOCHONDRIAL PYRUVATE CARRIER 2 (MPC2) ACETYLATION. J Biol Chem 292:4423-4433
Le, Yun-Zheng (2017) VEGF production and signaling in Müller glia are critical to modulating vascular function and neuronal integrity in diabetic retinopathy and hypoxic retinal vascular diseases. Vision Res 139:108-114
Qiu, Fangfang; Liu, Zhen; Zhou, Yueping et al. (2017) Decreased Circulating Levels of Dickkopf-1 in Patients with Exudative Age-related Macular Degeneration. Sci Rep 7:1263
He, Xuemin; Cheng, Rui; Park, Kyoungmin et al. (2017) Pigment epithelium-derived factor, a noninhibitory serine protease inhibitor, is renoprotective by inhibiting the Wnt pathway. Kidney Int 91:642-657
Jung, Dongju; Xu, Yuechi; Sun, Zhongjie (2017) Induction of anti-aging gene klotho with a small chemical compound that demethylates CpG islands. Oncotarget 8:46745-46755
Du, Mei; Phelps, Eric; Balangue, Michael J et al. (2017) Transgenic Mice Over-Expressing RBP4 Have RBP4-Dependent and Light-Independent Retinal Degeneration. Invest Ophthalmol Vis Sci 58:4375–4383
Shin, Younghwa; Moiseyev, Gennadiy; Chakraborty, Dibyendu et al. (2017) A Dominant Mutation in Rpe65, D477G, Delays Dark Adaptation and Disturbs the Visual Cycle in the Mutant Knock-In Mice. Am J Pathol 187:517-527

Showing the most recent 10 out of 94 publications